Simultaneous Positron Emission Tomography and Molecular Magnetic Resonance Imaging of Cardiopulmonary Fibrosis in a Mouse Model of Left Ventricular Dysfunction
Authors:
- Brianna F. MoonBMBrianna F. Moon
- Iris Y. ZhouIZIris Y. Zhou
- Yingying NingYNYingying Ning
- Yin‐Ching I. ChenYCYin‐Ching I. Chen
- Mariane Le FurMFMariane Le Fur
- Sergey ShuvaevSSSergey Shuvaev
- Eman A. AkamEAEman A. Akam
- Hua MaHMHua Ma
- Cesar Molinos SolsonaCSCesar Molinos Solsona
- Jonah Weigand‐WhittierJWJonah Weigand‐Whittier
- Lida P. HaririLHLida P. Hariri
Open Access
- 16 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (14) , e034363
Abstract
Background: Aging‐associated left ventricular dysfunction promotes cardiopulmonary fibrogenic remodeling, Group 2 pulmonary hypertension (PH), and right ventricular failure. At the time of diagnosis, cardiac function has declined, and cardiopulmonary fibrosis has often developed. Here, we sought to develop a molecular positron emission tomography (PET)–magnetic resonance imaging (MRI) protocol to detect both cardiopulmonary fibrosis and fibrotic disease activity in a left ventricular dysfunction model. Methods and Results: Left ventricular dysfunction was induced by transverse aortic constriction (TAC) in 6‐month‐old senescence‐accelerated prone mice, a subset of mice that received sham surgery. Three weeks after surgery, mice underwent simultaneous PET‐MRI at 4.7 T. Collagen‐targeted PET and fibrogenesis magnetic resonance (MR) probes were intravenously administered. PET signal was computed as myocardium‐ or lung‐to‐muscle ratio. Percent signal intensity increase and Δ lung‐to‐muscle ratio were computed from the pre‐/postinjection magnetic resonance images. Elevated allysine in the heart ( P =0.02) and lungs ( P =0.17) of TAC mice corresponded to an increase in myocardial magnetic resonance imaging percent signal intensity increase ( P P P P P =0.02) and lung (lung‐to‐muscle ratio, P <0.001) PET measurements. Pressure‐volume loop and echocardiography demonstrated adverse left ventricular remodeling, function, and increased right ventricular systolic pressure in TAC mice. Conclusions: Administration of collagen‐targeted PET and allysine‐targeted MR probes led to elevated PET–magnetic resonance imaging signals in the myocardium and lungs of TAC mice. The study demonstrates the potential to detect fibrosis and fibrogenesis in cardiopulmonary disease through a dual molecular PET–magnetic resonance imaging protocol.Keywords
This publication has 65 references indexed in Scilit:
- Integrated Cardiopulmonary MRI Assessment of Pulmonary HypertensionJournal of Magnetic Resonance Imaging, 2021
- Diffuse Right Ventricular Fibrosis in Heart Failure with Preserved Ejection Fraction and Pulmonary HypertensionESC Heart Failure, 2020
- Cardiovascular Aging and Heart FailureJACC, 2019
- Pulmonary Hypertension in Chronic Heart Failure: Definitions, Advances, and Unanswered IssuesESC Heart Failure, 2018
- Molecular Magnetic Resonance Imaging of Lung Fibrogenesis with an Oxyamine‐Based ProbeAngewandte Chemie International Edition, 2017
- The senescence accelerated mouse prone 8 (SAMP8): A novel murine model for cardiac agingAgeing Research Reviews, 2017
- Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection FractionCanadian Journal of Cardiology, 2015
- Pulmonary Hypertension Due to Left Heart DiseasesJACC, 2013
- World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2012
- Collagen‐Targeted MRI Contrast Agent for Molecular Imaging of FibrosisAngewandte Chemie International Edition, 2007